Accueil>>Signaling Pathways>> Others>>Antitumor Compound 1

Antitumor Compound 1

Catalog No.GC35363

Le composé antitumoral 1 est un composé puissant qui comprend une nouvelle imidazopyridine ayant une excellente activité antitumorale en tant qu'ingrédient actif.

Products are for research use only. Not for human use. We do not sell to patients.

Antitumor Compound 1 Chemical Structure

Cas No.: 420126-30-3

Taille Prix Stock Qté
10mM (in 1mL DMSO)
306,00 $US
En stock
2mg
216,00 $US
En stock
5mg
324,00 $US
En stock
10mg
464,00 $US
En stock
50mg
1 391,00 $US
En stock
100mg
1 947,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Antitumor Compound 1 is a potent compound which comprises a new imidazopyridine having excellent antitumor activity as an active ingredient.Reference:Polymer-linked imidazopyridines useful as tumor-targeting cytotoxic agentsBy Kasuya, Hiroshi; Miyazaki, Hideki; Hayakawa, Ichio; Kanno, Yuichi; Watanabe, KazuyoshiFrom Jpn. Kokai Tokkyo Koho (2004), JP 2004002826 A 20040108. Pharmaceuticals containing imidazopyridines for prophylactic and therapeutic treatment of tumorBy Hayakawa, Ichio; Kanno, Yuichi; Azuma, Toshiki; Furukawa, Hidehiko; Naruto, Shunji; Kurakata, ShinichiFrom Jpn. Kokai Tokkyo Koho (2003), JP 2003313126A 20031106.Preparation of imidazopyridine derivatives as antitumor agentsBy Hayakawa, Ichiro; Sugano, Yuichi; Agatsuma, Toshinori; Furukawa, Hidehiko; Kurakata, Shinichi; Naruto, ShunjiFrom PCT Int. Appl. (2002), WO 2002034748 A1 20020502.

Avis

Review for Antitumor Compound 1

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Antitumor Compound 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.